Disease directory
Mucocutaneous candidiasis
Published: September 18, 2026Updated: September 18, 2026
Important: Informational content intended for healthcare professionals. It does not replace clinical evaluation or establish a doctor-patient relationship.
Overview
Names: Mucocutaneous candidiasis; oropharyngeal candidiasis (“thrush”), cutaneous/intertriginous candidiasis, vulvovaginal candidiasis (VVC), Candida paronychia. Chronic Mucocutaneous Candidiasis (CMC) is a syndrome caused by IL-17/STAT1 immune defects.
First descriptions: Oral “Aphthae” already in Hippocrates; the fungal agent was attributed to a fungus in 1846-47 (Robin named it Oidium albicans ; today Candida albicans ).
Key epidemiology:
• VVC (vulvovaginal candidiasis) : very high prevalence; up to 75% of women will have ≥1 episode; recurrences (RVVC) ~5–8%.
• Oropharyngeal in HIV : remains one of the most common opportunistic infections (prevalence varies depending on context and ART)
• Cutaneous/intertrigo : common in skin folds, obesity, humidity, DM.
Codes:
ICD-10: B37.0 (stomatitis), B37.2 (skin/nail), B37.3 (vulva/vagina; subcodes B37.31 acute, B37.32 chronic), B37.9 (unspecified).
ICD-11 (group 1F23 candidiasis): 1F23.0 (lips/oral), 1F23.10 (vulvovaginal), 1F23.12 (intertriginous), 1F23.13 (nail/paronychia), 1F23.14 (CMC).
Doctors who treat Mucocutaneous candidiasis
Directory specialists related to Mucocutaneous candidiasis.
There are no specialists associated with this record yet
You can browse the full directory and filter by the condition you're interested in.
Go to directory